Tronox Holdings plc (NYSE: TROX) has reported a loss for its first fiscal quarter (ending March 31) of $-0.06 versus $0.15 for the same period a year ago — a decline of -140%. This result […]
The Chefs’ Warehouse Inc (NASDAQ: CHEF) has reported E.P.S. of $0.05 for its first fiscal quarter (ending March 31) versus $0.04 for the same period a year ago — an increase of 25%. Relative to […]
The Allstate Corporation (NYSE: ALL) has reported E.P.S. of $4.51 for its first fiscal quarter (ending March 31) versus $-1.31 for the same period a year ago. Relative to the consensus estimate of $4.68, this […]
Pilgrim’s Pride Corp (NASDAQ: PPC) has reported earnings for its first fiscal quarter (ending March 31) of $0.74 versus $0.02 for the same period a year ago — an increase of 3600%. This result exceeded […]
Pfizer Inc (NYSE: PFE) has reported E.P.S. of $0.55 for its first fiscal quarter (ending March 31) versus $0.98 for the same period a year ago — a decline of -44%. This performance was $-0.15 […]
For its second fiscal quarter (ending March 31), PTC Inc (NASDAQ: PTC) has reported a 78% increase in E.P.S. from $0.54 a year ago to $0.96 in the current quarter. Relative to the consensus estimate […]
OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) has reported earnings for its first fiscal quarter (ending March 31) of $1.53 versus $1.28 for the same period a year ago — an increase of 20%. However, this result […]
Norwegian Cruise Line Holdings L (NYSE: NCLH) has reported E.P.S. of $0.04 for its first fiscal quarter (ending March 31) versus $-0.38 for the same period a year ago. This performance was $-0.13 short of […]
For its first fiscal quarter (ending March 31), LivaNova PLC (NASDAQ: LIVN) has reported a -657% decline in E.P.S. from $0.14 a year ago to $-0.78 in the current quarter. Relative to the consensus estimate […]
For its second fiscal quarter (ending March 31), Johnson Controls International P (NYSE: JCI) has reported a -316% decline in E.P.S. from $0.19 a year ago to $-0.41 in the current quarter. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research